Molecular analysis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency in Hong Kong Chinese patients
Abstract
Background Congenital adrenal hyperplasia (CAH) caused by 21-hydroxylase deficiency (21OHD) is an autosomal recessive disorder due to mutation in the CYP21A2 gene.Objective To elucidate the genetic basis of 21-hydroxylase-deficient CAH in Hong Kong Chinese patients.Patients and methods Mutational analysis of the CYP21A2 gene was performed on 35 Hong Kong Chinese patients with 21OHD using direct DNA sequencing and multiplex ligation-dependent probe amplification (MLPA).Results The genetic findings of 21 male and 14 female patients are the following: c.293-13A/C>G (intron 2 splice site; 20 alleles), p.I172N (13), p.R356W (7), p.Q318X (4). A total of 20 mutant alleles contained gross deletion/conversion of all or part of the CYP21A2 gene. A novel mutation, c.1367delA (p.D456fs), was detected in one patient. One patient had only a heterozygous mutation detected. Out of 35 patients, 16 would have been incorrectly genotyped if either DNA sequencing or MLPA alone was used for molecular analysis.Conclusions The frequency of various mutations in the studied patients differs from those reported in other Asian populations. Gross deletion/conversion accounts for nearly one-third of the genetic defects. Therefore, laboratories must include methods for detecting point mutations as well as gross deletions/conversions to avoid misinterpretation of genotype. Genotyping has increasingly been proven to be a useful tool for supplementing, if not replacing, hormonal profiling for the diagnosis of 21OHD.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Cites
Speiser, P. W., Azziz, R., Baskin, L. S., Ghizzoni, L., Hensle, T. W., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Montori, V. M., Oberfield, S. E., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2631 · Cited by 1,484 · see citing works
Higashi, Y., Yoshioka, H., Yamane, M., Gotoh, O., & Fujii-Kuriyama, Y. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.9.2841 · Cited by 555 · see citing works
Krone, N., Braun, A., Roscher, A. A., Knorr, D., & Schwarz, H. P. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.3.6441 · Cited by 397 · see citing works
A recessive form of the Ehlers-Danlos syndrome caused by tenascin-X deficiency
Schalkwijk, J., Zweers, M. C., Steijlen, P. M., Dean, W. B., Taylor, G., van Vlijmen, I. M., van Haren, B., Miller, W. L., & Bristow, J. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa002939 · Cited by 391 · see citing works
Haploinsufficiency of TNXB Is Associated with Hypermobility Type of Ehlers-Danlos Syndrome
Zweers, M. C., Bristow, J., Steijlen, P. M., Dean, W. B., Hamel, B. C., Otero, M., Kucharekova, M., Boezeman, J. B., & Schalkwijk, J. (2003) · The American Journal of Human Genetics · doi:10.1086/376564 · Cited by 242 · see citing works
Finkielstain, G. P., Chen, W., Mehta, S. P., Fujimura, F. K., Hanna, R. M., Van Ryzin, C., McDonnell, N. B., & Merke, D. P. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0319 · Cited by 192 · see citing works
Higashi, Y., Tanae, A., Inoue, H., & Fujii-Kuriyama, Y. (1988) · Europe PMC (PubMed Central) · Cited by 173 · see citing works
Kharrat, M., Tardy, V., Mrad, R., Mâazoul, F., Jemâa, L. B., Refaï, M., Morel, Y., & Chaâbouni, H. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031056 · Cited by 88 · see citing works
Concolino, P., Mello, E., Toscano, V., Ameglio, F., Zuppi, C., & Capoluongo, E. (2009) · Clinica Chimica Acta · doi:10.1016/j.cca.2009.01.008 · Cited by 63 · see citing works
Friães, A., Rêgo, A. T., Aragüés, J. M., Moura, L. F., Mirante, A., Mascarenhas, M. R., Kay, T. T., Lopes, L. A., Rodrigues, J. C., Guerra, S., et al. (2006) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2005.11.015 · Cited by 63 · see citing works
Loidi, L., Quinteiro, C., Parajes, S., Barreiro, J., Lestón, D. G., Cabezas‐Agrícola, J. M., Sueiro, A. M., Araujo‐Vilar, D., Catro‐Feijóo, L., Costas, J., et al. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02465.x · Cited by 55 · see citing works
Speiser, P., Azziz, R., Baskin, L. S., Ghizzoni, L., Hensle, T. W., Merke, D. P., Meyer‐Bahlburg, H. F. L., Miller, W. L., Montori, V. M., Oberfield, S. E., et al. (2010) · International Journal of Pediatric Endocrinology · doi:10.1155/2010/494173 · Cited by 52 · see citing works
Molecular analysis of Japanese patients with steroid 21-hydroxylase deficiency
Asanuma, A., Ohura, T., Ogawa, E., Sato, S., Igarashi, Y., Matsubara, Y., & Iinuma, K. (1999) · Journal of Human Genetics · doi:10.1007/s100380050167 · Cited by 45 · see citing works
Molecular Analysis of CYP-21 Mutations for Congenital Adrenal Hyperplasia in Singapore
Loke, K. Y., Lee, Y. S., Lee, W. W. R., & Poh, L. K. S. (2001) · Hormone Research in Paediatrics · doi:10.1159/000049992 · Cited by 29 · see citing works
Koppens, P. F. J., Hoogenboezem, T., & DEGENHART, H. J. (2000) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5200543 · Cited by 29 · see citing works
Lee, H.-H., Lee, Y.-J., Wang, Y.-M., Chao, H.-T., Niu, D.-M., Chao, M.-C., Tsai, F.-J., Lo, F.-S., & Lin, S.-J. (2008) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2007.10.008 · Cited by 28 · see citing works
Campos, V. C., Pereira, R. M. C., Torres, N., de Castro, M., & Aguiar-Oliveira, M. H. (2009) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302009000100007 · Cited by 13 · see citing works
Goossens, K., Juniarto, A. Z., Timmerman, M. A., Faradz, S. M., Wolffenbuttel, K. P., Drop, S. L. S., & de Jong, F. H. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03550.x · Cited by 11 · see citing works
The Implication of De Novo 21-Hydroxylase Mutation in Clinical and Prenatal Molecular Diagnoses
Mao, R., McDonald, J., Cantwell, M., Tang, W. D., & Ward, K. J. (2005) · Genetic Testing · doi:10.1089/gte.2005.9.121 · Cited by 8 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management
Claahsen - van der Grinten, H. L., Speiser, P. W., Ahmed, S. F., Arlt, W., Auchus, R. J., Falhammar, H., Flück, C. E., Guasti, L., Huebner, A., Kortmann, B. B. M., et al. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab016 · Cited by 556 · see citing works
Xu, C., Jia, W., Cheng, X., Ying, H., Chen, J., Xu, J., Guan, Q., Zhou, X., Zheng, D., Li, G., et al. (2019) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.671 · Cited by 29 · see citing works
- Authors
- Chan, A. O. K., But, W. M., Ng, K. L., Wong, L. M., Lam, Y. Y., Tiu, S. C., Lee, K. F., Lee, C. Y., Loung, P. Y., Berry, I. R., Brown, R., Charlton, R., Cheng, C. W., Ho, Y. C., Tse, W. Y., & Shek, C. C.
- Affiliations
- Queen Elizabeth Hospital (CN)
- United Christian Hospital (CN)
- Tuen Mun Hospital (CN)
- Kwong Wah Hospital (CN)
- Caritas Medical Centre (CN)
- Princess Margaret Hospital (HK)
- St James's University Hospital (GB)
- Corresponding author
- Chan, Angel O.K.
- Venue
- Steroids
- Publisher
- Elsevier BV
- Published
- 2011-09
- Volume
- 76
- Issue
- 10-11
- Pages
- 1057-1062
- ISSN
- 0039-128X (ISSN-L)
- OpenAlex
- W2062303818
- Cited by
- 32
- References
- 19
- Citations by year
- 2025: 1 · 2024: 2 · 2022: 3 · 2021: 9 · 2020: 1 · 2019: 3 · 2018: 1 · 2017: 1 · 2016: 1 · 2015: 2 · 2014: 2 · 2013: 3 · 2012: 3
- FWCI
- 1.04
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Steroids (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Keywords
- congenital adrenal hyperplasia, 21-hydroxylase deficiency, CYP21A2 gene, CYP21A2 mutations, Hong Kong Chinese, novel frameshift mutation, genotyping, mutation frequency, autosomal recessive disorder
- MeSH terms
- Adrenal Hyperplasia, Congenital, Alleles, Child, Preschool, Female, Genotype, Hong Kong, Humans, Infant, Male, Mutation, Steroid 21-Hydroxylase, Asian People
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review